Monsanto (MON) Receives Average Rating of “Hold” from Brokerages

Monsanto (NYSE:MON) has been given a consensus recommendation of “Hold” by the seventeen analysts that are presently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, thirteen have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $125.94.

MON has been the topic of a number of recent analyst reports. ValuEngine upgraded Monsanto from a “hold” rating to a “buy” rating in a research report on Monday, April 9th. Argus lowered Monsanto from a “buy” rating to a “sell” rating in a research report on Monday, April 16th. BMO Capital Markets lowered Monsanto from an “outperform” rating to a “market perform” rating in a research report on Tuesday, April 10th. Zacks Investment Research lowered Monsanto from a “hold” rating to a “sell” rating in a research report on Monday, April 9th. Finally, Sanford C. Bernstein reiterated a “neutral” rating and set a $119.00 target price on shares of Monsanto in a research report on Monday, April 9th.

A number of hedge funds and other institutional investors have recently bought and sold shares of MON. Gradient Investments LLC acquired a new stake in shares of Monsanto in the 4th quarter worth $108,000. Bruderman Asset Management LLC acquired a new stake in shares of Monsanto in the 1st quarter worth $114,000. Private Capital Group LLC increased its stake in shares of Monsanto by 1,663.4% in the 1st quarter. Private Capital Group LLC now owns 1,252 shares of the basic materials company’s stock worth $146,000 after acquiring an additional 1,181 shares during the last quarter. Elkfork Partners LLC acquired a new stake in shares of Monsanto in the 4th quarter worth $162,000. Finally, Truewealth LLC acquired a new stake in shares of Monsanto in the 4th quarter worth $163,000. 74.99% of the stock is owned by hedge funds and other institutional investors.

Monsanto remained flat at $$127.95 during mid-day trading on Friday, Marketbeat reports. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.85 and a current ratio of 1.41. Monsanto has a 52 week low of $114.19 and a 52 week high of $127.97. The firm has a market cap of $56.40 billion, a P/E ratio of 23.26, a price-to-earnings-growth ratio of 2.64 and a beta of 0.97.

Monsanto (NYSE:MON) last announced its earnings results on Thursday, April 5th. The basic materials company reported $3.22 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.31 by ($0.09). Monsanto had a net margin of 17.07% and a return on equity of 37.31%. The business had revenue of $5.02 billion for the quarter, compared to analysts’ expectations of $5.34 billion. During the same quarter last year, the business earned $3.19 EPS. The company’s quarterly revenue was down 1.1% on a year-over-year basis. equities research analysts expect that Monsanto will post 5.7 earnings per share for the current year.

Monsanto Company Profile

Monsanto Company, together with its subsidiaries, provides agricultural products for farmers worldwide. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. The Seeds and Genomics segment produces row crop seeds, including corn, soybean, cotton, and canola seeds under the DEKALB, Asgrow, and Deltapine brands; and vegetable seeds, such as tomato, pepper, melon, cucumber, squash, beans, broccoli, onions, lettuce, and others under the Seminis and De Ruiter brands.

Analyst Recommendations for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply